|
31st European Meeting of The Toxicology Forum
Topics:
ICH Safety Guidelines for Pharmaceuticals - New Developments and European Aspects
-
The ICH Process, Its Impact and Updates on ICH Safety Guidelines
-
The Consideration of Three R's in the ICH Safety Guidelines - a Focus of the Commission
-
The Revision of the ICH Guideline on Safety Studies to Cover Clinical Trials
-
New Genotoxicity Testing Concepts Introduced with the Revision of the ICH Genotoxicity Guidelines
-
New ICH Guideline for Animal Safety Testing for Anti Cancer Agents
Special Aspects of Nanoparticle Risk Assessment
Prediction of Skin Sensitization Potential of Chemicals (in silico, in vitro, in vivo Methods)
-
“Sens-it-iv” 6th Framework Program Activities on the Development of Alternative Methods for Prediction of Skin Sensitization
-
COLIPA Strategy for Replacing Animal Testing for Prediction of Skin Sensitization
-
Validation of Reduced and Non-Radioactive LLNA methods
-
Integrated Approaches for Prediction of Skin Sensitization of Chemicals
-
Regulatory Perspective on the Use of Non-Animal Methods for Prediction of Skin Sensitization
Perfluorinated Fatty Acids Analogs – A Toxicologically Challenging Class of Chemicals
-
Exposure to Perfluorinated Chemicals in Man
-
Interspecies Differences of the Kinetics of PFOA and PFOS
-
Differential Activation of Nuclear Receptors and Hepatocarcinogenesis
-
Reproductive Toxicology in the Rat
-
Perfluorinated Chemicals and Fetal Growth
-
Suppression of Adaptive Immune Response by Perfluoro Octanic Acid?
Updates:
|